Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Intensitymodulated Radiotherapy Imrt

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT02113878Phase 1Completed

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

NCT03448341Completed

Dysphagia Assessment After Swallowing Sparing RadioTherapy

Showing all 2 trials

Research Network

Common Treatments

  • Intensitymodulated Radiotherapy Imrt1
  • Cisplatin1
  • Buparlisib1

Active Sponsors

  • Dana-Farber Cancer Institute1
  • Novartis Pharmaceuticals1
  • Azienda Ospedaliero, Universitaria Pisana1

Top Investigators

Related Conditions

  • Early Invasive Cervical Squamous Cell Carcinoma1
  • Hypopharyngeal Cancer1
  • Cancer Of Oropharynx1
  • Carcinoma Of Larynx1
  • Carcinoma Squamous Cell Of Head And Neck1

Activity Timeline